{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:58:00Z","timestamp":1793501880432,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nefroe.2025.101330","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:17:47Z","timestamp":1754579867000},"page":"101330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers"],"prefix":"10.1016","volume":"45","author":[{"given":"Alyaa","family":"Hliel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.101330_bib0275","first-page":"1009","article-title":"Study the level of zinc, copper and magnesium in Iraqi diabetic patients","volume":"20","author":"Jwaid","year":"2020","journal-title":"Biochem Cell Arch"},{"key":"10.1016\/j.nefroe.2025.101330_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.51173\/jt.v4i3.540","article-title":"The comparison and correlation of serum levels of insulin and Na+\/K+Atpase in type 2 diabetes mellitus (T2DM) and non-diabetes mellitus individuals","volume":"4","author":"Mohammed","year":"2022","journal-title":"J Tech"},{"issue":"V","key":"10.1016\/j.nefroe.2025.101330_bib0285","first-page":"431322","article-title":"Determination of adropin, body mass index and other biochemical parameters in Iraqi type II diabetic patients","author":"Chachan","year":"2022","journal-title":"Int J Health Sci"},{"issue":"Special Issue","key":"10.1016\/j.nefroe.2025.101330_bib0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.51173\/jt.v4i33.520","article-title":"Determination of cystatin c level in a sample of patients with chronic kidney disease","volume":"4","author":"Salman","year":"2022","journal-title":"J Tech"},{"key":"10.1016\/j.nefroe.2025.101330_bib0295","doi-asserted-by":"crossref","first-page":"e0297082","DOI":"10.1371\/journal.pone.0297082","article-title":"Determinants of diabetic nephropathy among diabetic patients in Ethiopia: systematic review and meta-analysis","volume":"19","author":"Azagew","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nefroe.2025.101330_bib0300","first-page":"88","article-title":"Assessment of transforming growth factor-beta (TGF-B) and albumin to creatinine ratio (ACR) in patients with type 2 diabetic nephropathy","volume":"11","author":"Abbas","year":"2022","journal-title":"World J Pharm Pharm Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0305","first-page":"007","article-title":"Assessment and correlation of serum urea and creatinine levels in normal, hypertensive, and diabetic persons in Auchi, Nigeria","volume":"7","author":"Akpotaire","year":"2023","journal-title":"Clin Res"},{"key":"10.1016\/j.nefroe.2025.101330_bib0310","doi-asserted-by":"crossref","first-page":"100435","DOI":"10.1016\/j.xkme.2022.100435","article-title":"Emerging role of clinical genetics in CKD","volume":"4","author":"Devarajan","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.nefroe.2025.101330_bib0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.54133\/ajms.v5i.167","article-title":"Correlation of kidney injury molecule-1 and nephrin levels in iraqi patients with diabetic nephropathy","volume":"5","author":"Aljorani","year":"2023","journal-title":"Al-Rafidain J Med Sci (2789\u20133219)"},{"key":"10.1016\/j.nefroe.2025.101330_bib0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.18137\/cardiometry.2024.31.105109","article-title":"The role of Monocyte Chemotactic Protein-3 (MCP3) in pyelonephritis patients in Al-Najaf Governorate","volume":"31","author":"Al-Janabi","year":"2024","journal-title":"Iraq Cardiometry"},{"key":"10.1016\/j.nefroe.2025.101330_bib0325","first-page":"3579","article-title":"The role of Monocyte Chemoattractant Protein-1 (MCP-1) in diabetic kidney disease","volume":"7","author":"Rahmatsyah","year":"2023","journal-title":"Biosci Med"},{"key":"10.1016\/j.nefroe.2025.101330_bib0330","doi-asserted-by":"crossref","first-page":"701547","DOI":"10.3389\/fcell.2021.701547","article-title":"The Wnt signaling pathway in diabetic nephropathy","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nefroe.2025.101330_bib0335","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2217\/bmm-2021-0177","article-title":"Wnt\/\u03b2-catenin pathway proteins in end-stage renal disease","volume":"15","author":"Al-Hakeim","year":"2021","journal-title":"Biomark Med"},{"key":"10.1016\/j.nefroe.2025.101330_bib0340","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/CS20210663","article-title":"WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-\u03baB pathway","volume":"136","author":"Wang","year":"2022","journal-title":"Clin Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0345","first-page":"41","article-title":"Assessment of ferritin level and some biochemical variables in iraqi anemic diabetic mellitus in both gender","volume":"1","author":"Bohan","year":"2024","journal-title":"J Al-Farabi Med Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0350","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.csbj.2021.03.003","article-title":"Association of risk factors with type 2 diabetes: a systematic review","volume":"19","author":"Ismail","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.nefroe.2025.101330_bib0355","first-page":"126","article-title":"A comparison between beta trace protein, cystatin C and creatinine for the estimation of eGFR in diabetic nephropathy","volume":"2","author":"Kamal","year":"2024","journal-title":"J Sci Med Life"},{"key":"10.1016\/j.nefroe.2025.101330_bib0360","doi-asserted-by":"crossref","first-page":"e81878","DOI":"10.7554\/eLife.81878","article-title":"Prediction of diabetic kidney disease risk using machine learning models: a population-based cohort study of Asian adults","volume":"12","author":"Sabanayagam","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.nefroe.2025.101330_bib0365","first-page":"1057","article-title":"Association of chymase and angiotensin II with early detection of diabetic nephropathy in patient with T2DM","volume":"23","author":"Nada","year":"2023","journal-title":"HIV Nurs"},{"key":"10.1016\/j.nefroe.2025.101330_bib0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.71146\/kjmr116","article-title":"Association of nephrin levels with chronic kidney disease in patients with hypertension","volume":"1","author":"Khalid","year":"2024","journal-title":"Kashf J Multidiscipl Res"},{"key":"10.1016\/j.nefroe.2025.101330_bib0375","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.2147\/DMSO.S432700","article-title":"Prevalence and risk factors of diabetic nephropathy among saudi type-1 diabetic patients in Taif City, Saudi Arabia","author":"Al-Zahrani","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.nefroe.2025.101330_bib0380","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.13005\/bpj\/2516","article-title":"The prediction of micro-and macrovascular complications in individuals with T2DM with different risk factors in Iraq","volume":"15","author":"Mana","year":"2022","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.nefroe.2025.101330_bib0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4239\/wjd.v15.i1.43","article-title":"Clinical study of different prediction models in predicting diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"15","author":"Cai","year":"2024","journal-title":"World J Diabetes"},{"key":"10.1016\/j.nefroe.2025.101330_bib0390","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijn.IJN_305_19","article-title":"A study of association of urinary nephrin with albuminuria in patients with diabetic nephropathy","volume":"31","author":"Kondapi","year":"2021","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.nefroe.2025.101330_bib0395","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2147\/DMSO.S305054","article-title":"The association between insulin resistance, leptin, and resistin and diabetic nephropathy in type 2 diabetes mellitus patients with different body mass indexes","volume":"14","author":"Huang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.nefroe.2025.101330_bib0400","doi-asserted-by":"crossref","first-page":"e25073","DOI":"10.34172\/jre.2024.25073","article-title":"Obesity-induced diabetic kidney disease-review on pathophysiology and clinical manifestations","volume":"10","author":"Ravi","year":"2024","journal-title":"J Renal Endocrinol"},{"key":"10.1016\/j.nefroe.2025.101330_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-01232-y","article-title":"Predictors of microalbuminuria and its relationship with glycemic control among Type 2 diabetic patients of Jazan Armed Forces Hospital, southwestern Saudi Arabia","volume":"22","author":"Abdelwahid","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.nefroe.2025.101330_bib0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.47723\/a2qf5d64","article-title":"Role of beta trace protein and cystatin c as a potential biomarker for early detection of type 2 diabetic nephropathy","volume":"20","author":"Kamal","year":"2024","journal-title":"AL-Kindy Coll Med J"},{"key":"10.1016\/j.nefroe.2025.101330_bib0415","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/jmisr.jmisr_3_22","article-title":"Cytokine profiling for Egyptian diabetic patients with nephropathy","volume":"5","author":"Abdel Gaffar","year":"2022","journal-title":"J Med Sci Res"},{"key":"10.1016\/j.nefroe.2025.101330_bib0420","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.21123\/bsj.2023.8008","article-title":"Early prediction of nephropathy in iraqi patient with diabetes type II by evaluating some relevant biochemical factors","volume":"21","author":"Ibrahim","year":"2023","journal-title":"Baghdad Sci J"},{"key":"10.1016\/j.nefroe.2025.101330_bib0425","doi-asserted-by":"crossref","first-page":"SP2312020","DOI":"10.36295\/ASRO.2020.231220","article-title":"Evaluation of urinary monocyte chemoattractant protein-1and serum cystatin c as markers for detection of diabetic nephropathy in comparison to albumin to creatinine ratio (ACR)","volume":"23","author":"Hataem","year":"2020","journal-title":"Ann Trop Med Public Health"},{"key":"10.1016\/j.nefroe.2025.101330_bib0430","article-title":"The correlation between creatinine levels and estimated glomerular filtration rate (GFR) with blood glucose levels in diabetes mellitus type 2 patients","volume":"12","author":"Riyani","year":"2024","journal-title":"Healthcare Low-resour Sett"},{"key":"10.1016\/j.nefroe.2025.101330_bib0435","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.21608\/ejhm.2023.288392","article-title":"Evalution of biomarkers in Iraq patients with diabetes mellitus type 2","volume":"90","author":"Jasem","year":"2023","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.nefroe.2025.101330_bib0440","doi-asserted-by":"crossref","first-page":"18","DOI":"10.22401\/ANJS.26.3.04","article-title":"Assessment of serum apelin level in Iraqi type 2 diabetic nephropathy patients","volume":"26","author":"Raheem","year":"2023","journal-title":"Al-Nahrain J Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0445","doi-asserted-by":"crossref","first-page":"646","DOI":"10.14704\/nq.2022.20.5.NQ22220","article-title":"Evaluation of physiological and immunological parameters in men with type 2 diabetic nephropathy","volume":"20","author":"AL-Fatlawi","year":"2022","journal-title":"NeuroQuantology"},{"key":"10.1016\/j.nefroe.2025.101330_bib0450","first-page":"33","article-title":"Role of novel biomarker monocyte chemo-attractant protein-1 in early diagnosis & predicting progression of diabetic kidney disease: a comprehensive review","volume":"116","author":"Swaminathan","year":"2024","journal-title":"J Natl Med Assoc"},{"issue":"S2","key":"10.1016\/j.nefroe.2025.101330_bib0455","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.53730\/ijhs.v6nS2.7049","article-title":"The role of MCP-1 in the developments of diabetic nephropathy in patients with type 2 diabetes mellitus patients","volume":"6","author":"Duaibel","year":"2022","journal-title":"Int J Health Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0460","series-title":"Clinical significance of urinary monocyte chemoattractant protein-1 (uMCP-1) and TNF-Alfa in indian type 2 diabetic patients at different stages of diabetic nephropathy","author":"Patnaik","year":"2020"},{"key":"10.1016\/j.nefroe.2025.101330_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.nefroe.2025.101330_bib0470","first-page":"1150","article-title":"NGAL KIM-1, and MCP-1 as biomarkers of kidney injury","volume":"6","author":"El-Absie","year":"2024","journal-title":"Afr J Biol Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0475","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12079-019-00536-4","article-title":"Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1\/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes","volume":"14","author":"Klimontov","year":"2020","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.nefroe.2025.101330_bib0480","first-page":"284","article-title":"Occurrence and development of diabetic nephropathy caused by CD63 by inhibiting Wnt-\u03b2-catenin signaling pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0485","first-page":"47","article-title":"Assessment of circulating Wnt1-inducible signaling pathway protein 1 (WISP1) in obesity and type 2 diabetes mellitus patients","volume":"2","author":"Habib","year":"2018","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"10.1016\/j.nefroe.2025.101330_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-05364-8","article-title":"An overview of CCN4 (WISP1) role in human diseases","volume":"22","author":"Singh","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.nefroe.2025.101330_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222111857","article-title":"Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis","volume":"22","author":"Hung","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0500","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/1516-3180.2019.0304.r2.09122019","article-title":"Association of serum levels of secreted frizzled-related protein 5 and Wnt member 5a with glomerular filtration rate in patients with type 2 diabetes mellitus and chronic renal disease: a cross-sectional study","volume":"138","author":"B\u00e1ez","year":"2020","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.nefroe.2025.101330_bib0505","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-\u03b2-catenin signalling\u2014a versatile player in kidney injury and repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2025.101330_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-018-1043-x","article-title":"Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease","volume":"19","author":"Satirapoj","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2025.101330_bib0515","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.3390\/ijms25073678","article-title":"Assessment and risk prediction of chronic kidney disease and kidney fibrosis using non-invasive biomarkers","volume":"25","author":"Rupprecht","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nefroe.2025.101330_bib0520","first-page":"248","article-title":"Increased serum WISP1 levels are associated with lower extremity atherosclerotic disease in patients with Type 2 diabetes mellitus","volume":"130","author":"Cheng","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.nefroe.2025.101330_bib0525","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.18632\/aging.205401","article-title":"Silencing of METTL3 prevents the proliferation, migration, epithelial-mesenchymal transition, and renal fibrosis of high glucose-induced HK2 cells by mediating WISP1 in m6A-dependent manner","volume":"16","author":"Chen","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.nefroe.2025.101330_bib0530","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1038\/s41598-024-53567-2","article-title":"Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study","volume":"14","author":"Fang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.nefroe.2025.101330_bib0535","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa029","article-title":"The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease","volume":"4","author":"Kravets","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.nefroe.2025.101330_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23136995","article-title":"The contribution of wnt signaling to vascular complications in type 2 diabetes mellitus","volume":"23","author":"Sanabria-de la Torre","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:07:54Z","timestamp":1757106474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251425000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2013251425000884"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.101330","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.101330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101330"}}